RAPT Therapeutics Valuation
| RAPT Stock | USD 1.05 0.02 1.87% |
Today, the entity appears to be undervalued. RAPT Therapeutics holds a recent Real Value of $11.21 per share. The prevailing price of the entity is $1.05. Our model determines the value of RAPT Therapeutics from inspecting the entity fundamentals such as Current Valuation of (55.38 M), return on asset of -0.47, and Shares Owned By Institutions of 86.65 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting RAPT Therapeutics' valuation include:
Price Book 0.3917 | Enterprise Value -55.4 M | Enterprise Value Ebitda (10.73) | Price Sales 411.2189 | Enterprise Value Revenue 677.3673 |
Undervalued
Today
Please note that RAPT Therapeutics' price fluctuation is moderately volatile at this time. Calculation of the real value of RAPT Therapeutics is based on 3 months time horizon. Increasing RAPT Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
RAPT Therapeutics' intrinsic value may or may not be the same as its current market price of 1.05, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.05 | Real 11.21 | Target 41.67 | Hype 1.26 | Naive 0.11 |
The intrinsic value of RAPT Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence RAPT Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of RAPT Therapeutics helps investors to forecast how RAPT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RAPT Therapeutics more accurately as focusing exclusively on RAPT Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use RAPT Therapeutics' intrinsic value based on its ongoing forecasts of RAPT Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against RAPT Therapeutics' closest peers.
RAPT Therapeutics Cash |
|
RAPT Valuation Trend
RAPT Therapeutics' real value is important for investors to make better decisions and a more accurate overall view of RAPT Therapeutics' financial worth over time. Using both RAPT Therapeutics' enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
RAPT Therapeutics Total Value Analysis
RAPT Therapeutics is at this time projected to have valuation of (55.38 M) with market capitalization of 37.41 M, debt of 6.91 M, and cash on hands of 207.34 M. The negative valuation of RAPT Therapeutics may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the RAPT Therapeutics fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(55.38 M) | 37.41 M | 6.91 M | 207.34 M |
RAPT Therapeutics Asset Utilization
One of the ways to look at asset utilization of RAPT is to check how much profit was generated for every dollar of assets it reports. RAPT Therapeutics holds a negative application of assets of -0.47 pct., losing $0.004658 for each dollar of assets held by the entity. Unsuccessful asset utilization implies the company is being less competent with each dollar of assets it holds. Put it differently, asset utilization of RAPT Therapeutics shows how unproductive it operates for each dollar spent on its assets.RAPT Therapeutics Ownership Allocation
RAPT Therapeutics owns a total of 34.96 Million outstanding shares. The majority of RAPT Therapeutics outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in RAPT Therapeutics to benefit from reduced commissions. Therefore, institutional investors are subject to a different set of regulations than regular investors in RAPT Therapeutics. Please pay attention to any change in the institutional holdings of RAPT Therapeutics as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the entity is less than the current market value, you may not be able to make money on it.RAPT Therapeutics Profitability Analysis
Net Loss for the year was (116.8 M) with profit before overhead, payroll, taxes, and interest of 1.53 M.About RAPT Therapeutics Valuation
The stock valuation mechanism determines RAPT Therapeutics' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of RAPT Therapeutics based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of RAPT Therapeutics. We calculate exposure to RAPT Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of RAPT Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -3.6 M | -3.4 M | |
| Pretax Profit Margin | (63.14) | (59.98) | |
| Operating Profit Margin | (64.61) | (61.38) | |
| Net Loss | (61.67) | (58.58) | |
| Gross Profit Margin | (0.96) | (0.92) |
RAPT Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as RAPT Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 38.3 M |
RAPT Therapeutics Current Valuation Indicators
RAPT Therapeutics' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final RAPT Therapeutics' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as RAPT Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use RAPT Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes RAPT Therapeutics' worth.Additional Tools for RAPT Stock Analysis
When running RAPT Therapeutics' price analysis, check to measure RAPT Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RAPT Therapeutics is operating at the current time. Most of RAPT Therapeutics' value examination focuses on studying past and present price action to predict the probability of RAPT Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RAPT Therapeutics' price. Additionally, you may evaluate how the addition of RAPT Therapeutics to your portfolios can decrease your overall portfolio volatility.